NO970340L - Organiske forbindelser - Google Patents

Organiske forbindelser

Info

Publication number
NO970340L
NO970340L NO970340A NO970340A NO970340L NO 970340 L NO970340 L NO 970340L NO 970340 A NO970340 A NO 970340A NO 970340 A NO970340 A NO 970340A NO 970340 L NO970340 L NO 970340L
Authority
NO
Norway
Prior art keywords
organic compounds
cyclopepolides
lcu
leu
diseases
Prior art date
Application number
NO970340A
Other languages
English (en)
Norwegian (no)
Other versions
NO970340D0 (no
Inventor
Michael Morris Dreyfuss
Carolyn Ann Foster
Hans-Ulrich Naegeli
Berndt Oberhauser
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9415168A external-priority patent/GB9415168D0/en
Priority claimed from GBGB9504332.9A external-priority patent/GB9504332D0/en
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of NO970340D0 publication Critical patent/NO970340D0/no
Publication of NO970340L publication Critical patent/NO970340L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K11/00Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K11/02Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof cyclic, e.g. valinomycins ; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14Fungi; Culture media therefor
    • C12N1/145Fungi isolates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/645Fungi ; Processes using fungi

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Botany (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Transplantation (AREA)
  • Physical Education & Sports Medicine (AREA)
  • AIDS & HIV (AREA)
NO970340A 1994-07-27 1997-01-27 Organiske forbindelser NO970340L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9415168A GB9415168D0 (en) 1994-07-27 1994-07-27 Organic compounds
GBGB9504332.9A GB9504332D0 (en) 1995-03-03 1995-03-03 Organic compounds
PCT/EP1995/002966 WO1996003430A1 (en) 1994-07-27 1995-07-26 Organic compounds

Publications (2)

Publication Number Publication Date
NO970340D0 NO970340D0 (no) 1997-01-27
NO970340L true NO970340L (no) 1997-01-27

Family

ID=26305345

Family Applications (1)

Application Number Title Priority Date Filing Date
NO970340A NO970340L (no) 1994-07-27 1997-01-27 Organiske forbindelser

Country Status (25)

Country Link
US (1) US6013627A (de)
EP (1) EP0775158B1 (de)
JP (1) JP3425763B2 (de)
KR (1) KR100378974B1 (de)
CN (1) CN1116304C (de)
AT (1) ATE187461T1 (de)
AU (1) AU702332B2 (de)
BR (1) BR9508342A (de)
CA (1) CA2192786C (de)
CY (1) CY2225B1 (de)
CZ (1) CZ289311B6 (de)
DE (1) DE69513837T2 (de)
DK (1) DK0775158T3 (de)
ES (1) ES2142490T3 (de)
FI (1) FI970279A7 (de)
GR (1) GR3032698T3 (de)
HU (1) HUT77388A (de)
MX (1) MX9606494A (de)
NO (1) NO970340L (de)
NZ (1) NZ291168A (de)
PL (1) PL181990B1 (de)
PT (1) PT775158E (de)
RU (1) RU2155772C2 (de)
SK (1) SK11797A3 (de)
WO (1) WO1996003430A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6187757B1 (en) 1995-06-07 2001-02-13 Ariad Pharmaceuticals, Inc. Regulation of biological events using novel compounds
US6011136A (en) * 1995-11-21 2000-01-04 Novartis Ag Cyclopeptolides
WO1999014082A1 (en) 1996-09-18 1999-03-25 Minnesota Mining And Manufacturing Company Adhesively-bonded inflatable restraint and method of making
US6365619B1 (en) 1999-07-22 2002-04-02 Novartis Ag Treatment of arteriosclerosis
US7067526B1 (en) 1999-08-24 2006-06-27 Ariad Gene Therapeutics, Inc. 28-epirapalogs
ES2219388T3 (es) * 1999-08-24 2004-12-01 Ariad Gene Therapeutics, Inc. 28-epi-rapalogos.
AU2002223649A1 (en) * 2000-10-27 2002-05-06 Novartis Ag Vegh inhibitors and their use
GB0028367D0 (en) * 2000-11-21 2001-01-03 Celltech Chiroscience Ltd Chemical compounds
GB0101598D0 (en) * 2001-01-22 2001-03-07 Novartis Ag Organic compounds
ATE457716T1 (de) 2002-12-30 2010-03-15 Angiotech Int Ag Wirkstofffreisetzung von schnell gelierender polymerzusammensetzung
EP2245165A4 (de) 2008-01-11 2011-06-01 Massachusetts Eye & Ear Infirm Transgene konditionalstopp-dimerisierbare-caspase-tiere
EP4491726A3 (de) 2013-06-11 2025-03-05 Takara Bio USA, Inc. Proteinangereicherte mikrovesikel und verfahren zur herstellung und verwendung davon

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4425428A (en) * 1982-04-08 1984-01-10 Monsanto Company Novel peptide and peptolide substrates for mammalian collagenase
US4443367A (en) * 1982-04-08 1984-04-17 Monsanto Company Peptide and peptolide substrates for mammalian collagenase
DE3851268T2 (de) * 1987-06-19 1995-01-26 Sandoz Ag Zyklische Peptolide.
DE3832059A1 (de) * 1988-09-21 1990-03-29 Howaldtswerke Deutsche Werft Tauchtiefengesteuerte ausblasventil-einrichtung
DE3832362A1 (de) * 1988-09-23 1990-03-29 Sandoz Ag Neue cyclopeptolide, verfahren zu ihrer herstellung und ihre verwendung

Also Published As

Publication number Publication date
CZ22197A3 (en) 1997-05-14
MX9606494A (es) 1997-03-29
CA2192786A1 (en) 1996-02-08
NO970340D0 (no) 1997-01-27
FI970279A0 (fi) 1997-01-23
EP0775158A1 (de) 1997-05-28
PT775158E (pt) 2000-05-31
NZ291168A (en) 1998-06-26
CN1116304C (zh) 2003-07-30
HK1014011A1 (en) 1999-09-17
CY2225B1 (en) 2003-04-18
EP0775158B1 (de) 1999-12-08
JPH10504540A (ja) 1998-05-06
RU2155772C2 (ru) 2000-09-10
CA2192786C (en) 2009-06-16
SK11797A3 (en) 1997-07-09
PL181990B1 (pl) 2001-10-31
US6013627A (en) 2000-01-11
AU702332B2 (en) 1999-02-18
FI970279L (fi) 1997-01-23
DE69513837D1 (de) 2000-01-13
AU3222195A (en) 1996-02-22
CN1154705A (zh) 1997-07-16
BR9508342A (pt) 1997-10-21
HUT77388A (hu) 1998-04-28
DK0775158T3 (da) 2000-05-22
JP3425763B2 (ja) 2003-07-14
DE69513837T2 (de) 2000-05-18
PL317349A1 (en) 1997-04-01
ES2142490T3 (es) 2000-04-16
WO1996003430A1 (en) 1996-02-08
ATE187461T1 (de) 1999-12-15
GR3032698T3 (en) 2000-06-30
FI970279A7 (fi) 1997-01-23
CZ289311B6 (cs) 2001-12-12
KR100378974B1 (ko) 2003-10-08

Similar Documents

Publication Publication Date Title
TR199801151T2 (xx) Trombin inhibit�r� �n ila�lar.
NO20075065L (no) Anvendelse av isoflavonforbindelser til a behandle hjertesykdom
NO20062292L (no) Fremgangsmate for behandling av transplantasjonsavstoting
ATE148130T1 (de) Typ-iv-dipeptidyl-aminopeptidase-inhibitoren
NO931695L (no) Nye 4-arylpiperaciner og 4-arylpiperidiner
NO20031192L (no) Isoksazoler og deres anvendelse som inhibitorer av ERK
TR200000059T2 (tr) Piridin türevleri
NO20051600L (no) 1,4-disubstituerte piperidinderivater og anvendelse derav som 11-betaHSD1 inhibitorer
NO20021358D0 (no) Alkylendiamin-substituerte heterocykler
NO983688L (no) Serin-protease-inhibitorer
NO970340L (no) Organiske forbindelser
ATE231837T1 (de) Hydroxamsäure- und carbonsäurederivate mit mmp und tnf hemmender wirkung
BR9811099A (pt) Inibidores de urocinase
PT734259E (pt) Utilizacao de derivados de piperidina para o tratamento da esquizofrenia
WO2000040583A3 (de) Imidazo[4,5-c]-pyridin-4-on-derivate
WO2001081332A3 (en) 2-fluorobenzenesulfonyl compounds for the treatment of inflammation
DE69808099D1 (de) Substituierte 6-alkylphenanthridine
WO2001091796A8 (en) Methods, compounds and compositions for treating gout
SE0004101D0 (sv) New use
NO20001758L (no) FremgangsmÕter og blandinger for behandling av leddgikt
NO20023111D0 (no) Utvortes preparat for behandling av pruritus
NO20022000L (no) 6-metoksy-2-naftyleddiksyre-prodrogesammensetninger til behandling av inflammasjon
BR0108002A (pt) Derivados de amidas heterocìclicas
DE69719218D1 (de) Verwendung von pvp oder povidone zum reduzieren von darmschwellungen
PT971714E (pt) Metodo utilizando inibidores ciclooxigenase-2 no tratamento e prevencao da demencia